These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 5700492)
41. [Liver support effect of experimental extracorporeal bioartificial liver]. Wang Y; Li M; Wang Y Zhonghua Gan Zang Bing Za Zhi; 1999 Mar; 7(1):31-3. PubMed ID: 10366983 [TBL] [Abstract][Full Text] [Related]
43. The hepatix extracorporeal liver assist device in the treatment of fulminant hepatic failure. Kelly JH; Sussman NL ASAIO J; 1994; 40(1):83-5. PubMed ID: 7514459 [No Abstract] [Full Text] [Related]
44. Circuitry and technique of extracorporeal porcine liver perfusion for the treatment of hepatic coma. Chalstrey LJ; Parbhoo SP Br J Surg; 1971 Jul; 58(7):522-4. PubMed ID: 5104472 [No Abstract] [Full Text] [Related]
45. Extracorporeal auxiliary xenoperfusion: animal model of support in fulminant liver failure. Argibay P; Vazquez J; Barros P; Vergé D; Nuñez F; Garcia H; Pekolj J; de Santibañes E Transplant Proc; 1996 Apr; 28(2):749-50. PubMed ID: 8623379 [No Abstract] [Full Text] [Related]
46. A successful case of extracorporeal pig-liver perfusion. Mieny CJ S Afr Med J; 1968 Oct; 42(40):1087-8. PubMed ID: 5749462 [No Abstract] [Full Text] [Related]
47. [Extracorporeal perfusion through the extra-situ isolated liver in the treatment of severe hepatic insufficiency]. Viola G; Livrea A; Parmeggiani U; Barbarisi A; Gentile A; De Pascale G; Leone CA Minerva Chir; 1978 Feb; 33(4):235-6. PubMed ID: 652180 [No Abstract] [Full Text] [Related]
48. Biocompatibility and bilirubin removal by diacetylchitin coated XAD-4. Matsushita M; Kawamata T; Koshino I; Kon T; Komai T; Fukui K; Nose Y Trans Am Soc Artif Intern Organs; 1985; 31():664-7. PubMed ID: 3837530 [No Abstract] [Full Text] [Related]
53. Disposable organ chamber for perfusion of the ex vivo liver and its use in the treatment of hepatic coma. Hanson C; Baker PR; Cuschieri A Eur Surg Res; 1974; 6(1):41-5. PubMed ID: 4851401 [No Abstract] [Full Text] [Related]
55. [Cholestasis and liver dysfunction in critical care patients]. Kredel M; Brederlau J; Roewer N; Wunder C Anaesthesist; 2008 Dec; 57(12):1172-82. PubMed ID: 18989650 [TBL] [Abstract][Full Text] [Related]
56. A case of syncytial giant-cell hepatitis treated with an extracorporeal liver assist device. Sussman NL; Finegold MJ; Barish JP; Kelly JH Am J Gastroenterol; 1994 Jul; 89(7):1077-82. PubMed ID: 7517100 [TBL] [Abstract][Full Text] [Related]
57. [Extracorporeal liver perfusion through the portal vein]. Alichniewicz A; Martin J; Zalech H; Joss A; Dziewaltowska D Pol Przegl Chir; 1969; 41(4):378-82. PubMed ID: 5785413 [No Abstract] [Full Text] [Related]
58. [Prospectives for using the extracorporeal connection of a xenospleen in treating patients with liver cirrhosis and obstructive jaundice complicated by liver failure]. Vakhidov AV; Kasymov ShZ; Kirichenko IP; Nazyrov FG; Kornienko VI; Akbarov MM Vestn Khir Im I I Grek; 1993; 150(1-2):90-2. PubMed ID: 7701715 [TBL] [Abstract][Full Text] [Related]
59. Effects of prostaglandin E(1) on the efficacy of xenogeneic extracorporeal pig liver perfusion in a canine model of acute liver failure. Takeyama O; Ikai I; Yagi T; Satoh S; Kanazawa A; Uesugi T; Nishitai R; Okabe H; Katsura N; Terajima H; Yamaoka Y Liver Transpl; 2001 Jun; 7(6):526-32. PubMed ID: 11443582 [TBL] [Abstract][Full Text] [Related]